Sharath Sharma

Breaking Free: The rise of corporate separations

David Dubner, Sharath Sharma, Allison Nathan

Driven by an elevated cost of capital and a strategic pivot toward simplification, over 30 global corporate separations were announced in 2022 as companies in sectors like pharmaceuticals and industrials seek to unlock portfolio discounts through operational focus. These transactions, typically closing within 9 to 13 months with internal leaders assuming over 80% of NewCo CEO roles, historically generate mid-single-digit outperformance against the S&P 500 within two years. By optimizing capital allocation and enabling targeted M&A, these divestitures serve as a critical mechanism for "shrinking to grow," allowing both RemainCos and NewCos to accelerate executive cycles and achieve value creation previously unattainable within diversified conglomerates.